Affiliation:
1. Almazov National Medical Research Centre
Abstract
TK2-associated mitochondrial myopathy is a clinically heterogeneous autosomal recessive disease characterized by a predominantly myopathic phenotype with variable age of onset. There are 3 main clinical forms depending on the age of onset: infantile, childhood (juvenile) and late onset (adult). The article presents a description of a clinical case of a patient with an infantile form of the disease with a significant positive effect of pathogenetic therapy with nucleosides.
Publisher
Arterialnaya Gipertenziya
Reference13 articles.
1. Garone C, Taylor RW, Nascimento A, et al. Retrospective natural history of thymidine kinase 2 deficiency. J Med Genet. August 2018;55(8):515–21.
2. Saada A, Shaag A, Mandel H, et al. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet. November 2001;29(3):342–4.
3. Wang J, El-Hattab AW, Wong LJC. TK2-Related Mitochondrial DNA Maintenance Defect, Myopathic Form. В: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Интернет]. Seattle (WA): University of Washington, Seattle; 1993 [цитируется по 24 октябрь 2021 г.]. Доступно на: http://www.ncbi.nlm.nih.gov/books/NBK114628/
4. Lopez-Gomez C, Hewan H, Sierra C, et al. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency. EBioMedicine. August 2019;46:356–67.
5. Finsterer J, Scorza FA, Fiorini AC, et al. TK2-related mitochondrial disorder is not restricted to the skeletal muscle. Mol Genet Metab Rep. September 2018;16:13–4.